Novartis AG (FRA:NOTA)

Market Cap	240.11B +25.4%
Revenue (ttm)	48.05B +12.9%
Net Income	12.27B -18.2%
EPS	6.22 -14.9%
Shares Out	n/a
PE Ratio	19.57
Forward PE	17.33
Dividend	3.10 (2.56%)
Ex-Dividend Date	Mar 12, 2025

Volume	n/a
Average Volume	35
Open	121.00
Previous Close	125.50
Day's Range	121.00 - 121.00
52-Week Range	88.20 - 130.00
Beta	n/a
RSI	52.60
Earnings Date	Feb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NOTA

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD